Interpace Biosciences (IDXG, $0.77) was a top loser over the last three months, falling -3 to $0.77 per share. A.I.dvisor analyzed 393 stocks in the Medical Specialties Industry for the 3-month period ending June 17, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.